Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: rrufff who wrote (19263)	3/31/2004 10:44:18 AM
From: Chris Forte	Read Replies (1) \| Respond to of 120405

rrufff, this is great news for CTE. It's further confirmation that the coronary artery bypass graft works. I consider this release as the company's way of saying, "Wow, the trials are going great - the graft is going to be a very SUCCESSFUL product." " Historical clinical data suggests that the majority of clinical problems are encountered in the first six months after implantation of a coronary graft." Sooner of later this product will make a huge splash on all the major media outlets...CNBC, ABC, CNN, Wall Street Journal...it's just a matter of time. CTE will be the stock du jour soon. Again this is great, great news for investors and for patients that need a bypass. Chris